Generic-Drug Co. Wants Gout Drug Antitrust Suit Tossed
Drugmaker Par Pharmaceutical Inc. told a Pennsylvania federal court it could not have participated in an alleged conspiracy to delay a generic version of Takeda Pharmaceuticals' anti-gout drug Colcrys because the...To view the full article, register now.
Already a subscriber? Click here to view full article